Steven Ades

7PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 06, 2026
Impact of Venous Thrombosis Prevention in Ambulatory Oncology: Importance of Guideline Adherence.

Chris E Holmes, Karlyn A Martin, Derek Devine

|May 06, 2023
A phase II study of alternating sunitinib and temsirolimus therapy in patients with metastatic renal cell carcinoma.

Dylan B Ness, Darcy B Pooler, Steven Ades

|Feb 07, 2022
Risk factors for venous thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER-Medicare analysis.

Steven Ades, Bhargavi Pulluri, Chris E Holmes

|Aug 02, 2021
Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect.

Steven Ades, Diego Adrianzen Herrera, Tim Lahey

|Mar 26, 2018
Effect of rosuvastatin on risk markers for venous thromboembolism in cancer.

S Ades, D Douce, C E Holmes

|Dec 30, 2016
Effectiveness of aprepitant in addition to ondansetron in the prevention of nausea and vomiting caused by fractionated radiotherapy to the upper abdomen (AVERT).

Steven Ades, M Halyard, K Wilson

Pageof 2

Frequent Collaborators

2 joint publications

Mary Cushman

2 joint publications

Chris Holmes

1 joint publications

Diego Adrianzen Herrera

1 joint publications

Maura Barry